| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 142943-51-9 | N-(4-Amino-1,2,3,6-Tetrahydro-1,3-Dimethyl-2,6-Dioxo-Pyrimidin-5-Yl)-2-(4-Chlorophenoxy)-Acetamide | C14H15ClN4O4 |
| 142944-48-7 | Urapidil Impurity 5 | C13H18BrClN2 |
| 142946-80-3 | 5,5'-Bis(trifluoromethyl)-2,2'-bipyridine | C12H6F6N2 |
| 142948-07-0 | 2'-Deoxy-8-(Phenylmethoxy)-Adenosine | C17H19N5O4 |
| 142948-08-1 | N-Benzoyl-2'-Deoxy-7,8-Dihydro-8-Oxo-Adenosine | C17H17N5O5 |
| 142950-86-5 | Triptoquinonoic acid A | C20H24O4 |
| 142955-50-8 | N-Boc-glycine N-Carboxyanhydride | C8H11NO5 |
| 142955-51-9 | (4S)-2,5-Dioxo-4-(Phenylmethyl)-3-Oxazolidinecarboxylic acid 1,1-Dimethylethyl Ester | C15H17NO5 |
| 142959-59-9 | N-[2-(2-Bromo-5-Methoxy-1H-Indol-3-Yl)Ethyl]-Acetamide | C13H15BrN2O2 |
| 142959-78-2 | Sperm-activating peptide III | C43H71N13O20 |
| 142959-87-3 | (2S,3R)-3-Butyryl-2-Oxiranecarboxamide | C7H11NO3 |
| 142959-88-4 | 3-(1-Hydroxybutyl)-2-Oxiranecarboxamide | C7H13NO3 |
| 142960-16-5 | (Tyr(5,12),Lys(7))-Polyphemusin II Peptide | C109H164N38O22S4 |
| 142960-30-3 | 1-Phenyl-1-Propen-2-Yl Octanoate | C17H24O2 |
| 142962-95-6 | Diacetato[(S)-(-)-2,2'-bis(diphenylphosphino)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl]ruthenium(II) | C48H46O4P2Ru |
| 142963-25-5 | 6-Methyl-6-Nitro-2-Heptanone | C8H15NO3 |
| 142963-63-1 | Acyclovir L-Isoleucinate | C14H22N6O4 |
| 142963-69-7 | Acyclovir L-Leucinate | C14H23ClN6O4 |
| 142966-21-0 | 4-Formyl-1-Methyl-5-Oxo-4,5-Dihydro-1H-Pyrazole-3-Carbonitrile | C6H5N3O2 |
| 142974-51-4 | (3beta,5beta,7alpha,12alpha)-7,12-Dihydroxy-3-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-Cholan-24-oic acid | C48H79NO8 |
| 142975-31-3 | (3a,5b,7a,12a)-3-Amino-7,12-dihydroxycholan-24-oic acid methyl ester | C25H43NO4 |
| 142975-51-7 | Cefaclor Dimer | C30H26Cl2N6O7S2 |
| 142975-81-3 | 5-Carboxy-2',7'-dichlorofluorescein | C21H10Cl2O7 |
| 142976-45-2 | (2R)-2-[(1R)-6,7-Dimethoxy-1,2,3,4-Tetrahydro-1-Isoquinolinyl]-1-Propanol | C14H21NO3 |
| 142978-18-5 | (2E)-2-Cyano-3-(2,3,6,7-Tetrahydro-1H,5H-Pyrido[3,2,1-Ij]Quinolin-9-Yl)Acrylic Acid | C16H16N2O2 |
| 142978-25-4 | {[1-(2-Hydroxyethyl)-1,2,3,4-Tetrahydro-6-Quinolinyl]Methyl}Malononitrile | C15H17N3O |
| 142979-40-6 | N-Benzoyl-2'-Deoxy-8-(Phenylmethoxy)-Adenosine | C24H23N5O5 |
| 142979-93-9 | S-[[4-(Benzoylsulfanylmethyl)-2,5-Dioxoimidazolidin-4-Yl]Methyl] Benzenecarbothioate | C19H16N2O4S2 |
| 142982-20-5 | Polydimethylsiloxane [(trimethoxysilyl)oxy]-terminated | |
| 142985-02-2 | 3-L-beta-Aspartic acid-somatoliberin (human pancreatic islet) | C215H358N72O66S |
| 142988-22-5 | Renin Fret Substrate I | C90H120N22O16S |
| 142991-74-0 | 2,2,2-Trifluoro-1-(2-Methyl-1H-Pyrrol-3-Yl)Ethanone | C7H6F3NO |
| 142992-99-2 | 3-Nitrophenylguanidine Nitrate | C7H9N5O5 |
| 142994-01-2 | 5-BroMo-2-Methylthioanisole | |
| 142994-02-3 | 4-Bromo-2-methylsulfonylbenzoic acid | C8H7BrO4S |
| 142994-03-4 | 4-Chloro-2-(Methylsulfonyl)Benzoic Acid | C8H7ClO4S |
| 142994-05-6 | 2-Methylsulfanyl-4-trifluoromethylbenzoic acid | C9H7F3O2S |
| 142994-06-7 | 2-Methylsulfonyl-4-trifluoromethylbenzoic acid | C9H7F3O4S |
| 142994-07-8 | 1-Bromo-2-methylsulfanyl-4-(trifluoromethyl)benzene | C8H6BrF3S |
| 142994-09-0 | 4-Chloro-2-(trifluoromethyl)benzoic acid | C8H4ClF3O2 |
| 142994-19-2 | Fmoc-4-chloro-D-phenylalanine | C24H20ClNO4 |
| 142994-45-4 | (R)-N-Fmoc-(3-Pyridyl)alanine | C23H20N2O4 |
| 142995-28-6 | 3,4-Dimethyl-L-Phenylalanine | |
| 142995-31-1 | Boc-3-(trifluoromethyl)-L-phenylalanine | C15H18F3NO4 |
| 142996-66-5 | 2,2,5,5-Tetramethyl-4-[[2-[[(Z)-(2,2,5,5-Tetramethyl-4-Oxooxolan-3-Ylidene)Methyl]Amino]Ethylamino]Methylidene]Oxolan-3-One | C20H32N2O4 |
| 142996-71-2 | (4E)-4-(Hydroxymethylene)-2,2-Dimethyldihydro-3(2H)-Furanone | C7H10O3 |
| 142997-31-7 | N-(3-Carboxy-1-oxopropyl)-L-alanyl-L-leucyl-L-prolyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-phenylalaninamide | C37H45N5O9 |
| 142997-58-8 | 4-Iodotomoxetine | C17H20INO |
| 142997-59-9 | 1-Hydroxyethyl-2'-deoxyadenosine | C12H17N5O4 |
| 142998-47-8 | Salvianolic acid D | C20H18O10 |